“As the health care system stakeholders wrestle with cost, quality and value must be factored in if you are thinking long term. My primary focus is helping clients translate how quality and value directly impact their market access strategy and how leveraging quality and value in those plans can ultimately create a path that supports continued innovation.”
Chris Juday, a Vice President at Discern Health, applies her deep experience in life sciences to connect with clients on a range of issues centered on health care quality and value. Having worked in a variety of life sciences roles, Chris can translate quality and value concepts into practical solutions for Discern’s clients. Chris has worked with national and regional organizations to implement new quality measures, initiate quality and value policy, and develop value-based arrangements and demonstrations. She is passionate about the importance of systemwide evaluation of value to drive health care decisions versus one of pure cost.
Prior to joining Discern, Chris was the lead for Quality and Value Policy at Sanofi, working closely with HEOR, Market Access, Government Affairs, and Advocacy colleagues internally to represent value-minded policies with national quality, advocacy, and trade organizations. She continues to serve as an active member of the University of Michigan’s Center for Value Based Insurance Design (VBID) Advisory Council and as a member of VBID Health’s Low Value Care Task Force.
Areas of Expertise
- Market access
- Value-based insurance design (VBID) and value-based arrangements
- Quality measurement
- Reimbursement policy
- MPH – University of Michigan
- BA – Michigan State University
- Grand Rapids, MI